Cross-sectional study assesses glucose and insulin levels in migraine patients, indicating insulin resistance may play a role.
Background: Migraine is a complex neurovascular disorder of the brain. Impaired glucose metabolism is suspected to have a potential role in the pathogenesis of migraine. Aims and Objectives: This study aimed to evaluate the association between fasting glucose, fasting insulin, and type 2 diabetes with migraine. Materials and Methods: A cross-sectional study was conducted involving 29 female patients diagnosed with migraine based on the international classification of headache disorders 3 criteria. Participants underwent physical examinations to assess obesity and metabolic syndrome. Serum insulin, homeostatic model assessment of insulin resistance (HOMA-IR), fasting blood glucose (FBG), and lipid profiles were measured. Results: The mean FBG (97.36±31.7) and total cholesterol (162.96±39.13), triglyceride, (112.5±49.51), low-density lipoprotein (99.43–28.90), and high-density lipoprotein (48.75±7.58) values were within normal limits. HOMA-IR was marginally elevated (mean 2.56±1.69; 95% conflict interval: 1.9–3.22), indicating insulin resistance (IR). A statistically significant difference in FBG was observed between patients with and without IR (median FBG: 90; U=29; z=−3.32; P=0.001) but no significant differences were found in body mass index or lipid profile (P>0.05). Conclusion: Impaired glucose metabolism was found to have an impact on migraine pathophysiology.
No takes yet. Share an insight, caveat, or question.
Gayen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: